Angiotensin-converting enzyme (ACE) inhibitor-induced acute pancreatitis: In search of the evidence

Southern Medical Journal

Volumn 99, Issue 12, 2006, Pages 1327-1328

  Singh, Sonal ^a,b,c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TELMISARTAN;

ACUTE PANCREATITIS; DATA BASE; DISEASE SEVERITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; LISINOPRIL; PANCREATITIS;

EID: 33845929937     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000232205.95465.02     Document Type: Editorial

References (25)

1. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol 2005;39:709-716.
2. Jeandidier N, Klewansky M, Pinget M. Captopril-induced acute pancreatitis. Diabetes Care 1995;18:410-411.
3. Iliopoulou A, Giannakopoulos G, Pagoy H, Christos T, Theodore S. Acute pancreatitis due to captopril treatment. Dig Dis Sci 2001;46:1882-1883.
4. Standridge JB. Fulminant pancreatitis associated with lisinopril therapy. South Med J 1994;87:179-181.
5. Marinella MA, Billi JE. Lisinopril therapy associated with acute pancreatitis. West J Med 1995;163:77-78.
6. Kanbay M, Sekuk H, Yilmaz U, et al. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig Dis 2005;23:92-94.
7. Maliekal J, Drake CF. Acute pancreatitis associated with the use of lisinopril. Ann Pharmacother 1993;27:1465-1466.
8. Gershon T, Olshaker JS. Acute pancreatitis following lisinopril rechallenge. Am J Emerg Med 1998;16:523-524.
9. Arjomand H, Kemp DG. Quinapril and pancreatitis. Am J Gastroenterol 1999;94:290-291.
10. Kanbay M, Korkmaz M, Yilmaz U, et al. Acute pancreatitis due to ramipril therapy. Postgrad Med J 2004;80:617-618.
11. Anagnostopoulos GK, Kostopoulos P, Tsiakos S, et al. Fulminant pancreatitis associated with ramipril therapy. Pancreas 2003;27:278-279.
12. Gallego-Rojo FJ, Gonzalez-Calvin JL, Guilarte J, et al. Perindopril-induced acute pancreatitis. Dig Dis Sci 1997;42:1789-91.
13. Tilkemeier P, Thompson PD. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988;318:1275-1276.
14. Martin T, Taupignon A, Graf E, et al. [Pancreatitis and hepatitis in a patient treated with enalapril maleate. A case report] Therapie 1989;44:449-450.
15. Gonzalez Ramallo VJ, Muino Miguez A, Torres Segovia FJ. Necrotizing pancreatitis and enalapril. Eur J Med 1992;1:123.
16. Maringhini A, Termini A, Patti R, et al. Enalapril-associated acute pancreatitis: recurrence after rechallenge. Am J Gastroenterol 1997;92:166-167.
17. Carnovale A, Esposito P, Bassano P, et al. Enalapril-induced acute recurrent pancreatitis. Dig Liver Dis 2003;35:55-57.
18. Baffoni L, Durante V, Grossi M. Acute pancreatitis induced by telmisartan overdose. Ann Pharmacother 2004;38:1088.
19. Kanbay M, Selcuk H, Yilmaz U. Recurrent acute pancreatitis secondary to lisinopril. South Med J 2006;99:1388-1389.
20. Diemont WL. Is this reaction caused by this drug? Neth J Med 2005;63:242-243.
21. Yamada T, Kuno A, Ogawa K, et al. Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. J Pharmacol Exp Ther 2005;313:36-45.
22. Eland IA, van Puijenbroek EP, Sturkenboom MJ, et al. Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol 1999;94:2417-2422.
23. Cheng RM, Mamdani M, Jackevicius CA, et al. Association between ACE inhibitors and acute pancreatitis in the elderly. Ann Pharmacother 2003;37:994-998.
24. Loke YK. Assessing the benefit-harm balance at the bedside. BMJ 2004;329:7-8.
25. Loke YK, Derry S, Aronson JK. A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone. Br J Clin Pharmacol 2004;57:616-621.